St. Joseph Inc (STJO) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of St. Joseph Inc $0.01, price $0.01, upside +88.3%, quality 41 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch St. Joseph Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range $0.0030 – $0.3297 · fair‑value band $0.0128 – $0.0188 · the $0.0077 price screens below the $0.0145 fair value. Dashed = 300-day average. As of Sep 23, 2026.
Follow St. Joseph in your weekly email
Every Wednesday you see whether St. Joseph is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
St. Joseph, Inc. does not have significant operations. Previously, it was engaged in the provision of staffing services. The company was formerly known as St. Joseph Energy, Inc. and changed its name to St. Joseph, Inc. in November 2003. St. Joseph, Inc. was incorporated in 1999 and is based in McKinney, Texas.
Stock analysis
St. Joseph Inc (STJO) currently trades at $0.0077, while our model-based Fair Value estimate is $0.0145, implying the stock looks roughly 46.9% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.
Scenario range: $0.0128 (bear) to $0.0188 (bull), the price of $0.0077 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
St. Joseph Inc reported revenue of $1.5M in FY2025 versus $0 in FY2015. Reported net income was −$14.4K in FY2025.
Key figures
Market cap $1.9M · EPS (TTM) $−0.0100 · Net margin −0.9% · Return on assets (EBIT) −4.7% · Free cash flow −$311K · Net debt $118K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 86% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at 88%, STJO screens cheaper than that median.
Fair Value models
Bear $0.0128Fair Value $0.0145Bull $0.0188
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.29/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−99.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+136.1%
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.5%
’07
’08
’09
’10
’11
’12
’13
’14
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−12.3% (2005) → −0.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks
Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score44 · Below median
Fair Value upside+45% · Top 25%
Profitability
Return on assets0% · Below median
Net margin (TTM)−1% · Below median
Operating margin (TTM)0% · Below median
Growth and dividend
Revenue growth0% · Below median
Valuation Multiplesvs Medical Devices median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "St. Joseph Inc Fair Value". https://www.fairvalue-calculator.com/stock/STJO
Frequently asked questions
Is St. Joseph Inc (STJO) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.0145 versus a price of $0.0077, about +88% upside (undervalued).
What is the fair value of STJO?
Our model-based fair value for St. Joseph Inc is $0.0145 (as of Sep 23, 2026), built from audited fundamentals. The current price: $0.0077.
What is the quality score of STJO?
St. Joseph Inc has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for St. Joseph Inc (STJO)?
Our model-based price target is the fair value of $0.0145 (as of Sep 23, 2026) from 1 valuation models. Cautious scenario $0.0128, optimistic scenario $0.0188. It is a calculation from audited fundamentals, not an analyst target.
What is the St. Joseph Inc stock forecast for 2026?
Our models put fair value at $0.0145, about +88% upside versus a price of $0.0077 (undervalued). Cautious scenario $0.0128, optimistic scenario $0.0188. The calculation is refreshed regularly with new filings.
What is the intrinsic value of St. Joseph Inc (STJO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For St. Joseph Inc it is $0.0145 per share (as of Sep 23, 2026), against a price of $0.0077. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is St. Joseph Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, STJO trades below its calculated fair value: price $0.0077, fair value $0.0145, a gap of about +88% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of STJO?
No. The price is what the market pays today ($0.0077); the fair value is what the company's own numbers justify ($0.0145). For St. Joseph Inc the two are $0.0068 per share apart. That gap is exactly why we show both numbers side by side.
How much is St. Joseph Inc worth?
The market values St. Joseph Inc at about $1.9M (market capitalisation, as of Sep 23, 2026). Per share that is $0.0077; our models calculate a fair value of $0.0145 per share.
What do the bullish and bearish scenarios say about STJO?
Our models span a range for St. Joseph Inc: cautious scenario $0.0128, base $0.0145, optimistic $0.0188 per share (as of Sep 23, 2026, price $0.0077). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is STJO from its 52-week high?
St. Joseph Inc trades at $0.0077, about 86% below its 52-week high of $0.0550 and 18% above the low of $0.0065 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0145 is for.
Which stocks are comparable to St. Joseph Inc?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is St. Joseph Inc stock attractive at the current price?
The data as of Sep 23, 2026: price $0.0077, calculated fair value $0.0145 (+88%), Quality Score 41/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of STJO calculated?
We run St. Joseph Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0145, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. St. Joseph Inc currently trades 88 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of St. Joseph Inc (STJO)?
The closing price on Sep 24, 2026 was $0.0077. Our model-based fair value is $0.0145, about +88% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with St. Joseph Inc right now?
The large discount to fair value meets weak quality (41/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0128). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of St. Joseph Inc
How large is the market capitalisation of St. Joseph Inc (STJO)?
The market capitalisation of St. Joseph Inc is $1.9M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of St. Joseph Inc (STJO)?
Earnings per share at St. Joseph Inc are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of St. Joseph Inc (STJO)?
The net margin of St. Joseph Inc is −0.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of St. Joseph Inc (STJO)?
On an EBIT basis the return on assets of St. Joseph Inc is −4.7% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does St. Joseph Inc (STJO) generate?
The free cash flow of St. Joseph Inc is −$311K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does St. Joseph Inc (STJO) carry?
The net debt of St. Joseph Inc is $118K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch St. Joseph Inc in the live analysis
One click puts St. Joseph Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 23, 2026